JP2000273031A - Protection cosmetic - Google Patents
Protection cosmeticInfo
- Publication number
- JP2000273031A JP2000273031A JP7699099A JP7699099A JP2000273031A JP 2000273031 A JP2000273031 A JP 2000273031A JP 7699099 A JP7699099 A JP 7699099A JP 7699099 A JP7699099 A JP 7699099A JP 2000273031 A JP2000273031 A JP 2000273031A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- vinylbenzyl
- weight
- sugar
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 59
- 229920000642 polymer Polymers 0.000 claims abstract description 32
- -1 poly(α- methylstyrene) Polymers 0.000 claims abstract description 26
- 229920001577 copolymer Polymers 0.000 claims abstract description 18
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000037307 sensitive skin Effects 0.000 claims abstract description 12
- 239000000178 monomer Substances 0.000 claims abstract description 11
- 239000000470 constituent Substances 0.000 claims abstract description 7
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004793 Polystyrene Substances 0.000 claims abstract description 4
- 229920003251 poly(α-methylstyrene) Polymers 0.000 claims abstract description 4
- 229920002223 polystyrene Polymers 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 3
- 239000004743 Polypropylene Substances 0.000 claims abstract description 3
- 239000008103 glucose Substances 0.000 claims abstract description 3
- 229920000515 polycarbonate Polymers 0.000 claims abstract description 3
- 239000004417 polycarbonate Substances 0.000 claims abstract description 3
- 229920001155 polypropylene Polymers 0.000 claims abstract description 3
- 229920002803 thermoplastic polyurethane Polymers 0.000 claims abstract description 3
- 150000003839 salts Chemical class 0.000 claims description 18
- 150000001720 carbohydrates Chemical group 0.000 claims description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 10
- 229920000307 polymer substrate Polymers 0.000 claims description 7
- KUQRLZZWFINMDP-BGNLRFAXSA-N 2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KUQRLZZWFINMDP-BGNLRFAXSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229920001519 homopolymer Polymers 0.000 claims description 5
- KUQRLZZWFINMDP-AIXJAHFHSA-N 2-[(3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O KUQRLZZWFINMDP-AIXJAHFHSA-N 0.000 claims description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 4
- 229920000178 Acrylic resin Polymers 0.000 claims description 3
- 239000004925 Acrylic resin Substances 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 229940097043 glucuronic acid Drugs 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims description 2
- 229920002050 silicone resin Polymers 0.000 claims description 2
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 claims 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- RPOKRGMOEWYIKB-ZFCLCKFASA-N (2r,3r,4r,5r)-n-[(4-ethenylphenyl)methyl]-2,3,6-trihydroxy-5-methyl-4-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanamide Chemical compound O([C@H]([C@@H](CO)C)[C@H](O)[C@@H](O)C(=O)NCC=1C=CC(C=C)=CC=1)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RPOKRGMOEWYIKB-ZFCLCKFASA-N 0.000 description 5
- NRWMBHYHFFGEEC-KTKRTIGZSA-N (9Z)-1-O-octadec-9-enyl glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-KTKRTIGZSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 5
- 229960002216 methylparaben Drugs 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- AJAJQFPSEMSLJB-UXOAXIEHSA-N (2R,3S,4R,5R)-2-benzyl-3-ethenyl-2,3,4,5,6-pentahydroxyhexanamide Chemical compound C(=C)[C@]([C@](C(=O)N)(O)CC1=CC=CC=C1)(O)[C@H](O)[C@H](O)CO AJAJQFPSEMSLJB-UXOAXIEHSA-N 0.000 description 1
- RQOANDUJOKVYJE-YIYPIFLZSA-N (2r,3s,4r,5r)-n-[(4-ethenylphenyl)methyl]-2,3,4,5,6-pentahydroxyhexanamide Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)NCC1=CC=C(C=C)C=C1 RQOANDUJOKVYJE-YIYPIFLZSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- LUMVCLJFHCTMCV-UHFFFAOYSA-M potassium;hydroxide;hydrate Chemical compound O.[OH-].[K+] LUMVCLJFHCTMCV-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- SONHXMAHPHADTF-UHFFFAOYSA-M sodium;2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O SONHXMAHPHADTF-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003459 sulfonic acid esters Chemical class 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、敏感肌の人に好適
な化粧料に関する。TECHNICAL FIELD The present invention relates to a cosmetic suitable for a person with sensitive skin.
【0002】[0002]
【従来の技術】近年の社会においては、種々のストレス
がそこで生活するものの上に降りかかってくる。この
為、現代社会に於いては、多くの人がストレスに由来す
る、疾病乃至は体の不調に悩んでいる。近年、化粧料の
世界に於いても、かつて経験したことがないほど、種々
の刺激に敏感な、いわゆる敏感肌の人が急増している背
景にも、この様なストレスの急増が原因となっていると
言われている。この様な、敏感肌の人は、普通の人が安
全に使用できる極めて安全性の高い界面活性剤などの製
剤成分に対しても過敏に反応してしまうため、化粧料が
殆ど使用できないのが現状となっている。この為、肌の
手入れなどに不都合が生じ、この様な人たちが安心して
使用できる化粧料の開発が望まれていた。この様な状況
の対応手段として、近年見出されてきた技術に、アクリ
ル酸・メタクリル酸アルキル(C10〜30)共重合体
及び/又はその塩を乳化剤兼増粘剤として用い、界面活
性剤の含有量を減らす技術が挙げられる。しかしなが
ら、このものは、乳化に充分なほど含有させるとぬめり
感が著しくなる場合があると言う欠点があり、含有量の
減量が望まれていた。このものの減量は、この様な観点
のみならず、使用感に於ける更なる刺激感の低減のため
にも必要であった。2. Description of the Related Art In recent society, various stresses fall on what lives there. For this reason, in modern society, many people are suffering from illness or physical disorder caused by stress. In recent years, even in the cosmetics world, people who are sensitive to various stimuli, so-called sensitive skin, have never experienced before. Is said to be. Since people with such sensitive skin also react sensitively to highly safe ingredients such as surfactants that can be used safely by ordinary people, cosmetics can hardly be used. It is the current situation. For this reason, inconvenience occurs in skin care and the like, and there has been a demand for the development of a cosmetic that can be used with peace of mind by such people. As a means for responding to such a situation, a technique which has been recently discovered includes a method of using a surfactant of an acrylic acid / alkyl methacrylate (C10-30) copolymer and / or a salt thereof as an emulsifier and a thickener. Techniques for reducing the content are mentioned. However, this has a drawback that the slimy feeling may become remarkable when it is contained sufficiently for emulsification, and it has been desired to reduce the content. The reduction of the weight was necessary not only from such a viewpoint but also for further reducing the irritating feeling in the usability.
【0003】一方、ポリマー基体に糖類を構成単位に含
む基を共有結合した、糖結合ポリマーは、化粧料用の保
湿素材として開発され(特開平6−122609号、特
開平5−43418号)、近年スキンケア化粧料などに
広く使用されているが、このものをアクリル酸・メタク
リル酸アルキル(C10〜30)共重合体とともに使用
することも、この様な組合せにより、敏感肌の人でも安
心して使用の出来、且つ使用感も優れる化粧料が提供で
きることも全く知られていなかった。On the other hand, a sugar-bonded polymer in which a group containing a saccharide in a structural unit is covalently bonded to a polymer substrate has been developed as a moisturizing material for cosmetics (JP-A-6-122609 and JP-A-5-43418). In recent years, it has been widely used in skin care cosmetics, etc., but it can be used with acrylic acid / alkyl methacrylate (C10-30) copolymers, and with such a combination, even people with sensitive skin can use it safely. It has not been known at all that it is possible to provide a cosmetic composition which is easy to use and has excellent usability.
【0004】[0004]
【発明が解決しようとする課題】本発明は、この様な状
況下為されたものであり、敏感肌の人でも安心して使用
でき、使用感にも優れる化粧料を提供することを課題と
する。DISCLOSURE OF THE INVENTION The present invention has been made under such circumstances, and it is an object of the present invention to provide a cosmetic composition which can be used safely by people with sensitive skin and which has an excellent feeling in use. .
【0005】[0005]
【課題の解決手段】本発明者らは、この様な状況に鑑み
て、敏感肌の人でも安心して使用でき、使用感にも優れ
る化粧料を求めて鋭意研究努力を重ねた結果、1)ポリ
マー基体に糖類を構成単位に含む基を共有結合した、糖
結合ポリマーと2)アクリル酸・メタクリル酸アルキル
(C10〜30)共重合体及び/又はその塩とを含有す
ることを特徴とする、化粧料にその様な性質を見出し、
発明を完成させるに至った。以下、本発明について、実
施の形態を中心に詳細に説明を加える。SUMMARY OF THE INVENTION In view of such circumstances, the present inventors have made intensive research efforts in search of cosmetics that can be used safely by even people with sensitive skin and have excellent usability. 1) A saccharide-bonded polymer in which a group containing a saccharide as a constituent unit is covalently bonded to a polymer substrate, and 2) an acrylic acid / alkyl methacrylate (C10 to 30) copolymer and / or a salt thereof, Finding such properties in cosmetics,
The invention has been completed. Hereinafter, the present invention will be described in detail focusing on embodiments.
【0006】[0006]
【発明の実施の形態】(1)本発明の化粧料の必須成分
であるポリマー基体に糖類を構成単位に含む基を共有結
合した、糖結合ポリマー 本発明の化粧料は、ポリマー基体に糖類を構成単位に含
む基を共有結合した、糖結合ポリマーを含有することを
特徴とする。これらの糖結合ポリマーは、ポリマーの基
体に糖を含む基が共有結合した形の化合物であって、い
わゆるペンダントタイプのポリマーである。この様な糖
結合ポリマーは、糖の有する優れた保湿作用を皮膚上で
持続する作用に優れ、しかも角質細胞間を接着させる作
用を有することが既に知られている。該糖結合ポリマー
のポリマー基体となるものは、通常一般的使用されてい
るポリマーであれば特段の限定なく使用することが出
来、例えば、ポリスチレン、ポリ(ーαーメチルスチレ
ン)、ポリ塩化ビニル、ポリビニルアルコール、ポリア
シルビニル、ポリアルキルビニル、ポリアミド、ポリエ
ステル、ポリプロピレン、ポリカーボネート、ウレタン
系樹脂、フッ素系樹脂、シリコーン及びアクリル系樹脂
が好ましく例示できる。この中で特に好ましいポリマー
は、ポリスチレンやポリ(−α−メチルスチレン)等の
スチレン系樹脂とポリアクリル酸、ポリメタクリル酸、
ポリアルキル酸エステル、ポリメタクリル酸エステルな
どのアクリル系樹脂である。更に、これらポリマーに共
有結合している糖構造を含有する基の糖の部分である
が、糖としては、通常の生体の構成要素として存在する
ものであれば特段の限定なく用いることが出来、例え
ば、グルコース、アラビノース、キシロース、ガラクト
ース、マンノース、フルクトース、グルコサミン、シア
ル酸及び/又はその塩、ムラミン酸及び/又はその塩、
グルクロン酸及び/又はその塩、ガラクツロン酸及び/
又はその塩並びにこれらの誘導体等が出来る。ここで、
誘導体とは、糖の水酸基をもとに容易に誘導しうる誘導
体であって、例えば、アセチル化体のようなアシル化
物、メチルエーテルのようなアルキル化物、スルホン酸
エステル及び/又はその塩等が好ましく例示できる。こ
れらは常法に従えば、容易に誘導できる。又、かかる糖
部分は、1ポリマー中に複数の種類が存在しても、唯一
種のみでも構わない。糖部分はポリマー基体に直接共有
結合で結合できるし、オキシ(C1−4)アルキル基等
の発明の効果を損なわない媒介基を介して共有結合して
も良い。この様な糖結合ポリマーの好ましい、構成モノ
マーとしては、N−p−ビニルベンジル−D−セロビオ
ンアミド、N−p−ビニルベンジル−D−ラクトンアミ
ド、N−p−ビニルベンジル−D−マルトンアミド、N
−p−ビニルベンジル−D−グルコンアミド、グルコシ
ルオキシエチルメタクリレート、ガラクトシルオキシプ
ロピルアクリレート、マンノシルオキシエチルメタクリ
レートが挙げられ、これらから選ばれる1種乃至は2種
以上を構成モノマーとして含むポリマーが本発明の好ま
しいポリマーである。ここで、本発明のポリマーとして
は、糖構造を有する基を有するこれらのモノマー以外
に、通常ポリマーで使用されているモノマーを構成モノ
マーとして含み、共重合体とすることもできるし、該糖
構造を有するモノマーのみの重合体や共重合体とするこ
ともできるが、より好ましいものは、該糖構造を有する
モノマーのみの重合体や共重合体である。即ち、言い換
えれば、N−p−ビニルベンジル−D−セロビオンアミ
ド、N−p−ビニルベンジル−D−ラクトンアミド、N
−p−ビニルベンジル−D−マルトンアミド、N−p−
ビニルベンジル−D−グルコンアミド、グルコシルオキ
シエチルメタクリレート、ガラクトシルオキシプロピル
アクリレート、マンノシルオキシエチルメタクリレート
から選ばれる1種乃至は2種以上のホモポリマー乃至は
コポリマーが特に好ましい。中でも、N−p−ビニルベ
ンジル−D−ラクトンアミドホモポリマー(PVLA)
とグルコシルオキシエチルメタクリレートホモポリマー
(PGEMA)が特に好ましい。これらのポリマーは、
前記モノマーを単独乃至は2種以上、場合によっては任
意の糖構造を有さないモノマーを加えて、過硫酸アンモ
ニウムやアゾビスイソブチロニトリル等の重合開始剤の
存在下、重合を行えば容易に得ることが出来る。この様
なポリマーの詳しい製法については、特開平6−122
609号や特開平5−43418号に記載されている。
本発明の化粧料に於いては、この様にして得られた、ポ
リマー基体に糖類を構成単位に含む基を共有結合した、
糖結合ポリマーから選ばれる1種乃至は2種以上を必須
成分として含有する。これらの成分は、本発明の化粧料
に於いて、皮膚に優れた保湿作用を示すと同時に、皮膚
がアレルギー反応等の好ましくない反応を起こすのを抑
制する作用を示す。更には、乳化剤である、アクリル酸
・メタクリル酸アルキル(C10〜30)共重合体及び
/又はその塩の量を減らし、このぬめり感を抑制する作
用を有する。これらの糖結合ポリマーの本発明の化粧料
に於ける好ましい含有量は、0.01〜10重量%であ
り、更に好ましくは0.05〜1重量%である。これは
少なすぎると上記作用が発現しない場合があり、多すぎ
てもこの様な作用は頭打ちになり、剤形的な制限が生じ
ることがあるためである。BEST MODE FOR CARRYING OUT THE INVENTION (1) Sugar-bonded polymer in which a saccharide-containing group is covalently bonded to a polymer base which is an essential component of the cosmetic of the present invention. It is characterized by containing a sugar-binding polymer in which the group contained in the structural unit is covalently bonded. These sugar-binding polymers are compounds in which a group containing a sugar is covalently bonded to the base of the polymer, and are so-called pendant type polymers. It is already known that such a sugar-binding polymer is excellent in sustaining the excellent moisturizing action of sugar on the skin, and has an action of adhering between keratinocytes. As the polymer substrate of the sugar-bonded polymer, any generally used polymer can be used without particular limitation. Examples thereof include polystyrene, poly (-α-methylstyrene), polyvinyl chloride, and polyvinyl alcohol. , Polyacylvinyl, polyalkylvinyl, polyamide, polyester, polypropylene, polycarbonate, urethane resin, fluorine resin, silicone and acrylic resin. Among them, particularly preferred polymers are styrene resins such as polystyrene and poly (-α-methylstyrene) and polyacrylic acid, polymethacrylic acid,
Acrylic resins such as polyalkyl acid esters and polymethacrylic acid esters. Furthermore, the saccharide moiety of a group containing a saccharide structure covalently bonded to these polymers can be used without any particular limitation as long as the saccharide is present as a component of a normal living body. For example, glucose, arabinose, xylose, galactose, mannose, fructose, glucosamine, sialic acid and / or a salt thereof, muramic acid and / or a salt thereof,
Glucuronic acid and / or a salt thereof, galacturonic acid and / or
Or salts thereof, derivatives thereof, and the like. here,
A derivative is a derivative that can be easily derived based on the hydroxyl group of a sugar, and examples thereof include an acylated product such as an acetylated product, an alkylated product such as methyl ether, a sulfonic acid ester and / or a salt thereof. It can be preferably exemplified. These can be easily derived according to a conventional method. In addition, such a sugar moiety may be a plurality of kinds in one polymer, or may be only one kind. The sugar moiety can be directly covalently bonded to the polymer substrate, or may be covalently bonded via an intermediary group such as an oxy (C1-4) alkyl group which does not impair the effects of the present invention. Preferred constituent monomers of such a sugar-binding polymer include Np-vinylbenzyl-D-cellobionamide, Np-vinylbenzyl-D-lactonamide, Np-vinylbenzyl-D-maltonamide , N
-P-vinylbenzyl-D-gluconamide, glucosyloxyethyl methacrylate, galactosyloxypropyl acrylate, mannosyloxyethyl methacrylate, and a polymer containing one or more selected from these as a constituent monomer. Preferred polymers. Here, as the polymer of the present invention, in addition to these monomers having a group having a sugar structure, a monomer which is usually used in a polymer may be contained as a constituent monomer, and a copolymer may be used. It is also possible to use a polymer or copolymer of only a monomer having a saccharide structure, but more preferable is a polymer or copolymer of only a monomer having a saccharide structure. That is, in other words, Np-vinylbenzyl-D-cellobionamide, Np-vinylbenzyl-D-lactone amide,
-P-vinylbenzyl-D-maltonamide, Np-
One or more homopolymers or copolymers selected from vinylbenzyl-D-gluconamide, glucosyloxyethyl methacrylate, galactosyloxypropyl acrylate, and mannosyloxyethyl methacrylate are particularly preferred. Among them, Np-vinylbenzyl-D-lactone amide homopolymer (PVLA)
And glucosyloxyethyl methacrylate homopolymer (PGEMA) are particularly preferred. These polymers are
The above-mentioned monomer alone or two or more kinds thereof may be easily added by adding a monomer having no arbitrary sugar structure in the presence of a polymerization initiator such as ammonium persulfate or azobisisobutyronitrile. Can be obtained. For a detailed production method of such a polymer, see JP-A-6-122.
609 and JP-A-5-43418.
In the cosmetic of the present invention, a group containing a saccharide as a constituent unit is covalently bonded to the polymer substrate obtained in this manner.
One or more selected from sugar-binding polymers are contained as essential components. These components, in the cosmetic of the present invention, exhibit an excellent moisturizing effect on the skin, and at the same time, exhibit an effect of suppressing the skin from causing an undesired reaction such as an allergic reaction. Furthermore, it has the effect of reducing the amount of an emulsifier, an acrylic acid / alkyl methacrylate (C10-30) copolymer and / or a salt thereof, and suppressing this slimy feeling. The content of these sugar-binding polymers in the cosmetic of the present invention is preferably 0.01 to 10% by weight, more preferably 0.05 to 1% by weight. This is because if the amount is too small, the above-mentioned effect may not be exhibited, and if the amount is too large, such an effect may reach a peak and a dosage form may be restricted.
【0007】(2)本発明の化粧料の必須成分であるア
クリル酸・メタクリル酸アルキル(C10〜30)共重
合体及び/又はその塩 本発明の化粧料は、アクリル酸・メタクリル酸(C10
〜30)共重合体及び/又はその塩を含有することを特
徴とする。このものは、常法に従い製造することもでき
る。例えば、メタクリル酸ナトリウムなどのメタクリル
酸の塩と長鎖アルキルナトリウムアルコキシドとを縮合
させ、メタクリル酸長鎖アルキルエステルを作成し、こ
のものとアクリル酸とを重合させればよい。この様に、
調整したものを使用することもできるが、この様な共重
合体は既に市販をされており、このものを利用すること
もできる。この様な市販品としては、例えば、グッドリ
ッチ社より市販されている、ペムレンTR−1やペムレ
ンTR−2等が好ましく例示できる。これらは唯一種を
含有させることもできるし、二種以上を組み合わせて含
有させることもできる。このものは、本発明の化粧料に
おいては、界面活性剤が少ない或いはない系を乳化し、
該乳化を安定化し、敏感肌の人が刺激を受けることを防
止する作用を有する。本発明の化粧料に於ける、これら
アクリル酸・メタクリル酸アルキル(C10〜30)共
重合体及び/又はその塩の好ましい含有量は、総量で、
0.01〜10重量%であり、更に好ましくは、0.0
5〜5重量%である。これは多すぎると、使用感や系そ
のものの安定性を損なうことがあり、少なすぎると上記
効果が発現しない場合があるからである。又、塩として
は化粧料で通常使用されているものであれば、特段の限
定なく使用することができ、例えば、カリウムやナトリ
ウムなどのアルカリ金属塩、マグネシウム塩、カルシウ
ムなどのアルカリ土類金属塩、アンモニウム塩、トリエ
タノールアミンやトリエチルアミンなどの有機アミン
塩、リジンやアルギニンなどの塩基性アミノ酸塩等が好
ましく例示できる。(2) Acrylic acid / alkyl methacrylate (C10-30) copolymer and / or a salt thereof, which are essential components of the cosmetic of the present invention, are made of acrylic acid / methacrylic acid (C10
~ 30) It is characterized by containing a copolymer and / or a salt thereof. This can also be manufactured according to a conventional method. For example, a salt of methacrylic acid such as sodium methacrylate and a long-chain alkyl sodium alkoxide may be condensed to prepare a long-chain alkyl methacrylate, and this may be polymerized with acrylic acid. Like this
Adjusted ones can be used, but such copolymers are already commercially available and can also be used. Preferable examples of such commercially available products include Pemulen TR-1 and Pemulen TR-2, which are commercially available from Goodrich. These may contain only one kind, or may contain two or more kinds in combination. This emulsifies a system with little or no surfactant in the cosmetic of the present invention,
It has an effect of stabilizing the emulsification and preventing a person with sensitive skin from being stimulated. In the cosmetic of the present invention, the preferable content of the acrylic acid / alkyl methacrylate (C10-30) copolymer and / or a salt thereof is, in total,
0.01 to 10% by weight, more preferably 0.0 to 10% by weight.
5 to 5% by weight. If the amount is too large, the feeling of use or the stability of the system itself may be impaired. If the amount is too small, the above-mentioned effects may not be exhibited. In addition, as the salt, those usually used in cosmetics can be used without particular limitation, for example, alkali metal salts such as potassium and sodium, magnesium salts, and alkaline earth metal salts such as calcium. , Ammonium salts, organic amine salts such as triethanolamine and triethylamine, and basic amino acid salts such as lysine and arginine.
【0008】(3)本発明の化粧料 本発明の化粧料は、通常市場に於いて使用されている化
粧料であれば、特段の制限なく、例えば、基礎化粧料、
メークアップ化粧料、毛髪化粧料、洗浄用化粧料など
に、適用することが出来るが、好ましいのは、敏感肌の
人が使用する皮膚化粧料である。本発明の化粧料の、糖
結合ポリマーに起因する、安全性の高さは、アクリル酸
・メタクリル酸アルキル(C10〜30)共重合体に敏
感な人であっても使用可能に為しうる効果を発揮する。
従って、本発明の化粧料は、敏感肌用の化粧料に適用す
るのが特に好ましい。本発明の化粧料に於いては、上記
必須成分以外に、通常化粧料で使用される任意成分を本
発明の化粧料の効果を損なわない範囲に於いて使用でき
る。かかる任意成分としては、例えば、ワセリンやマイ
クロクリスタリンワックス等のような炭化水素類、ホホ
バ油やゲイロウ等のエステル類、牛脂、オリーブ油等の
トリグリセライド類、セタノール、オレイルアルコール
等の高級アルコール類、ステアリン酸、オレイン酸等の
脂肪酸、グリセリンや1,3−ブタンジオール等の多価
アルコール類、非イオン界面活性剤、アニオン界面活性
剤、カチオン界面活性剤、両性界面活性剤、エタノー
ル、カーボポール等の増粘剤、防腐剤、紫外線吸収剤、
抗酸化剤、色素、粉体類等が好ましく例示できる。本発
明の化粧料は、これらの成分を常法に従って処理するこ
とにより製造することが出来る。(3) Cosmetic of the Present Invention The cosmetic of the present invention is not particularly limited as long as it is a cosmetic that is usually used in the market, for example, basic cosmetics,
It can be applied to make-up cosmetics, hair cosmetics, cleansing cosmetics, etc., but preferred are skin cosmetics used by people with sensitive skin. The high safety attributed to the sugar-binding polymer of the cosmetic of the present invention can be used even by a person who is sensitive to an acrylic acid / alkyl methacrylate (C10-30) copolymer. Demonstrate.
Therefore, it is particularly preferable to apply the cosmetic of the present invention to cosmetics for sensitive skin. In the cosmetic of the present invention, in addition to the above-mentioned essential components, optional components usually used in cosmetics can be used as long as the effects of the cosmetic of the present invention are not impaired. Examples of such optional components include hydrocarbons such as petrolatum and microcrystalline wax, esters such as jojoba oil and gay wax, triglycerides such as tallow, olive oil, higher alcohols such as cetanol and oleyl alcohol, and stearic acid. Fatty acids such as oleic acid, polyhydric alcohols such as glycerin and 1,3-butanediol, nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, ethanol, carbopol, etc. Viscous agent, preservative, UV absorber,
Preferred examples include antioxidants, dyes, and powders. The cosmetic of the present invention can be produced by treating these components according to a conventional method.
【0009】[0009]
【実施例】以下に実施例を挙げて、本発明について更に
詳細に説明を加えるが、本発明がこれら実施例にのみ限
定を受けないことは言うまでもない。EXAMPLES The present invention will be described in more detail with reference to the following examples, but it goes without saying that the present invention is not limited to these examples.
【0010】<実施例1、2>下記に示す処方に従っ
て、本発明の化粧料を作成した。即ち、イ、ロ、ハの成
分をそれぞれ80℃に加熱し、イにロを加え中和し、こ
れに徐々に撹拌しながらハを加え乳化し、ホモジナイザ
ーで粒子を均一にした後、撹拌冷却し、本発明の化粧料
である、乳液を得た。又、PGEMAを全てペムレンT
R−2に置換した比較例1とペムレンTR−2を全てP
GEMAに置換した比較例2も作成してみたが、比較例
2は乳化せずサンプル作成が不可能であった。これらの
安定性(40℃、10日間)も調べた。 イ ペムレンTR−2* PGEMA(分子量100000)* グリセリン 3 重量部 1,3−ブタンジオール 5 重量部 メチルパラベン 0.1重量部 水 50 重量部 ロ 水酸化カリウム* 水* ハ スクワラン 5 重量部 グリセリンモノオレイルエーテル 2 重量部 セタノール 3 重量部 *詳細の含有量(重量部)は表1に示す。<Examples 1 and 2> Cosmetics of the present invention were prepared according to the following formulation. That is, the components (a), (b) and (c) are each heated to 80 ° C., (b) is neutralized by adding (b) to (a) and emulsified by adding (c) while gradually stirring the mixture. Then, an emulsion, which is the cosmetic of the present invention, was obtained. In addition, PGEMA is all Pemulen T
Comparative Example 1 substituted with R-2 and Pemulen TR-2 were all P
Comparative Example 2 in which GEMA was substituted was also prepared, but Comparative Example 2 was not emulsified and a sample could not be prepared. Their stability (40 ° C., 10 days) was also investigated. I Pemulen TR-2 * PGEMA (molecular weight 100,000) * Glycerin 3 parts by weight 1,3-butanediol 5 parts by weight Methyl paraben 0.1 parts by weight Water 50 parts by weight b Potassium hydroxide * Water * 5 parts by weight glycerin monooleyl Ether 2 parts by weight Cetanol 3 parts by weight * Details (parts by weight) are shown in Table 1.
【0011】[0011]
【表1】 [Table 1]
【0012】<実施例3>上記実施例1、2及び比較例
1の乳液について、その使用感を専門家により評価し
た。評価項目はしっとり感とべたつきのなさであり、そ
の評価基準は、++:非常によい、+:良い、±:やや
良い、−:悪いであった。結果を表2に示す。これよ
り、本発明の化粧料である、実施例1、2の乳液は、し
っとり感に優れるにも関わらず、べたつきがないという
優れた使用感を有することがわかる。<Example 3> With respect to the emulsions of Examples 1 and 2 and Comparative Example 1, the feeling of use was evaluated by an expert. The evaluation items were moist feeling and non-stickiness, and the evaluation criteria were ++: very good, +: good, ±: slightly good,-: bad. Table 2 shows the results. From this, it can be seen that the emulsions of Examples 1 and 2, which are the cosmetics of the present invention, are excellent in moist feeling, but have an excellent feeling of use without stickiness.
【0013】[0013]
【表2】 [Table 2]
【0014】<実施例4>上記実施例1、2及び比較例
1の乳液について、モルモット損傷皮膚を用いた皮膚刺
激試験を行った。即ち、ハートレー系白色種モルモット
(雄性、300〜400g)1群6匹の背部を剃毛し、
ガムテープストリッピングした後、上記検体を48時間
クローズドパッチした。パッチ絆創膏の除去後1時間
に、皮膚反応をドレーズの基準に従って判定した。即
ち、++:浮腫を伴う反応、+:明らかな紅斑を伴う反
応、±:微弱な紅斑を伴う反応、−:無反応である。結
果を表3に示す。これより、本発明の化粧料である乳液
は極めて安全性に優れることがわかる。Example 4 A skin irritation test was performed on the emulsions of Examples 1 and 2 and Comparative Example 1 using guinea pig damaged skin. That is, the back of a group of six Hartley white guinea pigs (male, 300 to 400 g) was shaved,
After stripping the gum tape, the sample was closed patched for 48 hours. One hour after removal of the patch, the skin response was determined according to Draize criteria. That is, ++: reaction with edema, +: reaction with clear erythema, ±: reaction with weak erythema,-: no reaction. Table 3 shows the results. This indicates that the emulsion of the cosmetic of the present invention is extremely safe.
【0015】[0015]
【表3】 [Table 3]
【0016】<実施例5>実施例1、2及び比較例1の
サンプルについて、アレルギー惹起抑制作用を調べた。
即ち、モルモット50匹をマキシマイゼーションテスト
の手法に従って、0.5%ホルマリン水溶液で、4回の
皮内注射(フロインドのコンプリートアジュバント存在
下)と2回の48時間クローズドパッチの処理により、
感作し、2週間の休止期間の後に、0.05%ホルマリ
ン水溶液の24時間クローズドパッチで陽性になった動
物7匹の背部を剃毛し、2cm×2cmの部位を4つ作
成し、これらのサンプル及び水を各部位に0.05ml
投与した。その後、部位全体を0.1%のホルマリン水
溶液を含浸したパッチ絆創膏で覆い、24時間クローズ
ドパッチした。パッチ絆創膏の除去後1時間にドレーズ
の基準で皮膚反応を判定した。結果を表4に示す。これ
より、本発明の化粧料はアレルギー惹起抑制作用を有す
ることがわかる。このことから、本発明の化粧料はアト
ピー性皮膚炎など外部刺激に敏感になっている人に適用
するのに適していることがわかる。<Example 5> The samples of Examples 1 and 2 and Comparative Example 1 were examined for their allergy-inducing effect.
That is, 50 guinea pigs were subjected to four intradermal injections (in the presence of Freund's complete adjuvant) and two 48-hour closed patch treatments with a 0.5% aqueous formalin solution according to the maximization test method.
After sensitization and a 2-week rest period, the backs of seven animals that were positive with a closed patch of 0.05% aqueous formalin for 24 hours were shaved and four 2 cm × 2 cm sites were formed. 0.05 ml of sample and water in each part
Was administered. Thereafter, the entire site was covered with a patch bandage impregnated with a 0.1% formalin aqueous solution and closed for 24 hours. One hour after removal of the patch, the skin response was determined by Draise criteria. Table 4 shows the results. This indicates that the cosmetic of the present invention has an allergy-inducing effect. This indicates that the cosmetic of the present invention is suitable for applying to people who are sensitive to external stimuli such as atopic dermatitis.
【0017】[0017]
【表4】 [Table 4]
【0018】<実施例6、7>下記に示す処方に従っ
て、本発明の化粧料を作成した。即ち、イ、ロ、ハの成
分をそれぞれ80℃に加熱し、イにロを加え中和し、こ
れに徐々に撹拌しながらハを加え乳化し、ホモジナイザ
ーで粒子を均一にした後、撹拌冷却し、本発明の化粧料
である、乳液を得た。又、PVLAを全てペムレンTR
−2に置換した比較例1とペムレンTR−2を全てPV
LAに置換した比較例3も作成してみたが、比較例3は
乳化せずサンプル作成が不可能であった。これらの安定
性(40℃、10日間)も調べた。 イ ペムレンTR−2** PVLA(分子量20000)** グリセリン 3 重量部 1,3−ブタンジオール 5 重量部 メチルパラベン 0.1重量部 水 50 重量部 ロ 水酸化カリウム** 水** ハ スクワラン 5 重量部 グリセリンモノオレイルエーテル 2 重量部 セタノール 3 重量部 **詳細の含有量(重量部)は表5に示す。実施例3と同様に評価した結果もあ わせて示す。PVLAもPGEMA同様の効果を有することがわかる。<Examples 6 and 7> Cosmetics of the present invention were prepared according to the following formulation. That is, the components (a), (b) and (c) are each heated to 80 ° C., (b) is neutralized by adding (b) to (a) and emulsified by adding (c) while gradually stirring the mixture. Then, an emulsion, which is the cosmetic of the present invention, was obtained. In addition, all PVLA is Pemren TR
Comparative Example 1 and Pemulen TR-2 in which
Although Comparative Example 3 in which LA was substituted was also prepared, Comparative Example 3 was not emulsified and a sample could not be prepared. Their stability (40 ° C., 10 days) was also investigated. I Pemulen TR-2 ** PVLA (Molecular weight 20,000) ** Glycerin 3 parts by weight 1,3-butanediol 5 parts by weight Methylparaben 0.1 parts by weight Water 50 parts by weight b Potassium hydroxide ** Water ** HA Squalane 5 parts by weight Parts glycerin monooleyl ether 2 parts by weight Cetanol 3 parts by weight ** Details of contents (parts by weight) are shown in Table 5. The results evaluated in the same manner as in Example 3 are also shown. It can be seen that PVLA has the same effect as PGEMA.
【0019】[0019]
【表5】 [Table 5]
【0020】<実施例8>下記に示す処方に従って、本
発明の化粧料を作成した。即ち、イ、ロ、ハの成分をそ
れぞれ80℃に加熱し、イにロを加え中和し、これに徐
々に撹拌しながらハを加え乳化し、ホモジナイザーで粒
子を均一にした後、撹拌冷却し、本発明の化粧料であ
る、乳液を得た。これらの安定性(40℃、10日間)
を調べたところ、全く問題はなかった。更に、しっとり
感やべたつき感も++であった。 イ ペムレンTR−1 0.2重量部 PVLA(分子量20000) 0.1重量部 グリセリン 3 重量部 1,3−ブタンジオール 5 重量部 メチルパラベン 0.1重量部 水 50 重量部 ロ 水酸化カリウム 0.2重量部 水 31.4重量部 ハ スクワラン 5 重量部 グリセリンモノオレイルエーテル 2 重量部 セタノール 3 重量部Example 8 A cosmetic of the present invention was prepared according to the following formulation. That is, the components (a), (b) and (c) are each heated to 80 ° C., (b) is neutralized by adding (b) to (a) and emulsified by adding (c) while gradually stirring the mixture, homogenizing the particles with a homogenizer, and then stirring and cooling. Then, an emulsion, which is the cosmetic of the present invention, was obtained. Their stability (40 ° C, 10 days)
I found no problem at all. Further, the moist feeling and the sticky feeling were also ++. I Pemulen TR-1 0.2 parts by weight PVLA (molecular weight 20,000) 0.1 part by weight Glycerin 3 parts by weight 1,3-butanediol 5 parts by weight Methylparaben 0.1 parts by weight Water 50 parts by weight potassium hydroxide 0.2 Parts by weight water 31.4 parts by weight squalane 5 parts by weight glycerin monooleyl ether 2 parts by weight cetanol 3 parts by weight
【0021】<実施例9>下記に示す処方に従って、本
発明の化粧料を作成した。即ち、イ、ロ、ハの成分をそ
れぞれ80℃に加熱し、イにロを加え中和し、これに徐
々に撹拌しながらハを加え乳化し、ホモジナイザーで粒
子を均一にした後、撹拌冷却し、本発明の化粧料であ
る、乳液を得た。これらの安定性(40℃、10日間)
を調べたところ、全く問題はなかった。更に、しっとり
感やべたつき感も++であった。 イ ペムレンTR−1 0.2重量部 PGEMA(分子量100000) 0.1重量部 グリセリン 3 重量部 1,3−ブタンジオール 5 重量部 メチルパラベン 0.1重量部 水 50 重量部 ロ 水酸化カリウム 0.2重量部 水 31.4重量部 ハ スクワラン 5 重量部 グリセリンモノオレイルエーテル 2 重量部 セタノール 3 重量部Example 9 A cosmetic of the present invention was prepared according to the following formulation. That is, the components (a), (b) and (c) are each heated to 80 ° C., (b) is neutralized by adding (b) to (a) and emulsified by adding (c) while gradually stirring the mixture, homogenizing the particles with a homogenizer, and then stirring and cooling. Then, an emulsion, which is the cosmetic of the present invention, was obtained. Their stability (40 ° C, 10 days)
I found no problem at all. Further, the moist feeling and the sticky feeling were also ++. I Pemulen TR-1 0.2 parts by weight PGEMA (molecular weight 100,000) 0.1 part by weight Glycerin 3 parts by weight 1,3-butanediol 5 parts by weight Methylparaben 0.1 parts by weight Water 50 parts by weight potassium hydroxide 0.2 Parts by weight water 31.4 parts by weight squalane 5 parts by weight glycerin monooleyl ether 2 parts by weight cetanol 3 parts by weight
【0022】<実施例10>下記に示す処方に従って、
本発明の化粧料を作成した。即ち、イ、ロ、ハの成分を
それぞれ80℃に加熱し、イにロを加え中和し、これに
徐々に撹拌しながらハを加え乳化し、ホモジナイザーで
粒子を均一にした後、撹拌冷却し、本発明の化粧料であ
る、乳液を得た。これらの安定性(40℃、30日間)
を調べたところ、全く問題はなかった。更に、しっとり
感やべたつき感も++であった。 イ ペムレンTR−1 0.2重量部 PGEMA(分子量50000) 1 重量部 グリセリン 3 重量部 1,3−ブタンジオール 5 重量部 メチルパラベン 0.1重量部 水 50 重量部 ロ 水酸化カリウム 0.2重量部 水 30.5重量部 ハ スクワラン 5 重量部 グリセリンモノオレイルエーテル 2 重量部 セタノール 3 重量部Example 10 According to the following formulation,
The cosmetic of the present invention was prepared. That is, the components (a), (b) and (c) are each heated to 80 ° C., (b) is neutralized by adding (b) to (a) and emulsified by adding (c) while gradually stirring the mixture. Then, an emulsion, which is the cosmetic of the present invention, was obtained. Their stability (40 ° C, 30 days)
I found no problem at all. Further, the moist feeling and the sticky feeling were also ++. I Pemulen TR-1 0.2 parts by weight PGEMA (molecular weight 50,000) 1 part by weight Glycerin 3 parts by weight 1,3-butanediol 5 parts by weight Methylparaben 0.1 parts by weight Water 50 parts by weight 0.2 parts by weight of potassium hydroxide Water 30.5 parts by weight Hassqualane 5 parts by weight Glycerin monooleyl ether 2 parts by weight Cetanol 3 parts by weight
【0023】[0023]
【発明の効果】本発明によれば、敏感肌の人でも安心し
て使用でき、使用感にも優れる化粧料を提供することが
できる。According to the present invention, it is possible to provide a cosmetic composition which can be used safely even by a person with sensitive skin and which has an excellent feeling upon use.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 安藤 信裕 神奈川県横浜市戸塚区柏尾町560 ポーラ 化成工業株式会社戸塚研究所内 Fターム(参考) 4C083 AB032 AC022 AC072 AC122 AC172 AC482 AD091 AD092 AD391 AD392 CC05 DD31 EE06 EE10 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Nobuhiro Ando 560, Kashio-cho, Totsuka-ku, Yokohama-shi, Kanagawa Prefecture F-term in the Totsuka Research Laboratory 4C083 AB032 AC022 AC072 AC122 AC172 AC482 AD091 AD092 AD391 AD392 CC05 DD31 EE06 EE10
Claims (6)
む基を共有結合した、糖結合ポリマーと2)アクリル酸
・メタクリル酸アルキル(C10〜30)共重合体及び
/又はその塩とを含有することを特徴とする、化粧料。1. Containing 1) a sugar-bonded polymer in which a group containing a saccharide is covalently bonded to a polymer substrate and 2) a copolymer of acrylic acid and alkyl methacrylate (C10-30) and / or a salt thereof. Cosmetics characterized by doing.
(ーαーメチルスチレン)、ポリアミド、ポリエステ
ル、ポリプロピレン、ポリカーボネート、ウレタン系樹
脂、フッ素系樹脂、シリコーン及びアクリル系樹脂から
選ばれるものであることを特徴とする、請求項1に記載
の化粧料。2. The method according to claim 1, wherein the polymer substrate is selected from polystyrene, poly (-α-methylstyrene), polyamide, polyester, polypropylene, polycarbonate, urethane resin, fluorine resin, silicone and acrylic resin. The cosmetic according to claim 1.
シロース、ガラクトース、マンノース、フルクトース、
グルコサミン、シアル酸及び/又はその塩、ムラミン酸
及び/又はその塩、グルクロン酸及び/又はその塩、ガ
ラクツロン酸及び/又はその塩並びにこれらの誘導体か
ら選ばれる1種乃至は2種以上であることを特徴とす
る、請求項1又は2に記載の化粧料。3. The saccharide is glucose, arabinose, xylose, galactose, mannose, fructose,
One or more selected from glucosamine, sialic acid and / or a salt thereof, muramic acid and / or a salt thereof, glucuronic acid and / or a salt thereof, galacturonic acid and / or a salt thereof, and derivatives thereof The cosmetic according to claim 1 or 2, characterized in that:
ル−D−セロビオンアミド、N−p−ビニルベンジル−
D−ラクトンアミド、N−p−ビニルベンジル−D−マ
ルトンアミド、N−p−ビニルベンジル−D−グルコン
アミド、グルコシルオキシエチルメタクリレート、ガラ
クトシルオキシプロピルアクリレート、マンノシルオキ
シエチルメタクリレートから選ばれる1種乃至は2種以
上を構成単量体として含むホモポリマー乃至はコポリマ
ーであることを特徴とする、請求項1〜3の何れか一項
に記載の化粧料。4. The method according to claim 1, wherein the sugar-binding polymer is Np-vinylbenzyl-D-cellobionamide, Np-vinylbenzyl-
One or more selected from D-lactone amide, Np-vinylbenzyl-D-maltonamide, Np-vinylbenzyl-D-gluconamide, glucosyloxyethyl methacrylate, galactosyloxypropyl acrylate, and mannosyloxyethyl methacrylate The cosmetic according to any one of claims 1 to 3, wherein the cosmetic is a homopolymer or a copolymer containing two or more kinds as constituent monomers.
ル−D−セロビオンアミド、N−p−ビニルベンジル−
D−ラクトンアミド、N−p−ビニルベンジル−D−マ
ルトンアミド、N−p−ビニルベンジル−D−グルコン
アミド、グルコシルオキシエチルメタクリレート、ガラ
クトシルオキシプロピルアクリレート、マンノシルオキ
シエチルメタクリレートから選ばれる1種乃至は2種以
上のホモポリマー乃至はコポリマーであることを特徴と
する、請求項1〜4の何れか一項に記載の化粧料。5. The method according to claim 5, wherein the sugar-binding polymer is Np-vinylbenzyl-D-cellobionamide, Np-vinylbenzyl-
One or more selected from D-lactone amide, Np-vinylbenzyl-D-maltonamide, Np-vinylbenzyl-D-gluconamide, glucosyloxyethyl methacrylate, galactosyloxypropyl acrylate, and mannosyloxyethyl methacrylate The cosmetic according to any one of claims 1 to 4, wherein the cosmetic is at least two kinds of homopolymers or copolymers.
請求項1〜5の何れか一項に記載の化粧料。6. It is for a person with sensitive skin,
The cosmetic according to any one of claims 1 to 5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7699099A JP2000273031A (en) | 1999-03-23 | 1999-03-23 | Protection cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7699099A JP2000273031A (en) | 1999-03-23 | 1999-03-23 | Protection cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000273031A true JP2000273031A (en) | 2000-10-03 |
| JP2000273031A5 JP2000273031A5 (en) | 2006-04-13 |
Family
ID=13621227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7699099A Pending JP2000273031A (en) | 1999-03-23 | 1999-03-23 | Protection cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000273031A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005306796A (en) * | 2004-04-23 | 2005-11-04 | Pola Chem Ind Inc | Skin care external preparation having anti-inflammatory activity |
| JP2006028100A (en) * | 2004-07-16 | 2006-02-02 | Pola Chem Ind Inc | External preparation for skin having antiinflammatory activity |
| JP2006028099A (en) * | 2004-07-16 | 2006-02-02 | Pola Chem Ind Inc | External preparation for skin having rough skin-ameliorating activity |
| JP2006028094A (en) * | 2004-07-16 | 2006-02-02 | Pola Chem Ind Inc | External preparation for skin having antiinflammatory activity |
| JP2006347962A (en) * | 2005-06-16 | 2006-12-28 | Shiseido Co Ltd | Cleaning composition for skin and hair |
| JP2015113298A (en) * | 2013-12-10 | 2015-06-22 | 花王株式会社 | Cosmetic composition |
| JP2015113297A (en) * | 2013-12-10 | 2015-06-22 | 花王株式会社 | Cosmetic composition |
-
1999
- 1999-03-23 JP JP7699099A patent/JP2000273031A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005306796A (en) * | 2004-04-23 | 2005-11-04 | Pola Chem Ind Inc | Skin care external preparation having anti-inflammatory activity |
| JP2006028100A (en) * | 2004-07-16 | 2006-02-02 | Pola Chem Ind Inc | External preparation for skin having antiinflammatory activity |
| JP2006028099A (en) * | 2004-07-16 | 2006-02-02 | Pola Chem Ind Inc | External preparation for skin having rough skin-ameliorating activity |
| JP2006028094A (en) * | 2004-07-16 | 2006-02-02 | Pola Chem Ind Inc | External preparation for skin having antiinflammatory activity |
| JP2006347962A (en) * | 2005-06-16 | 2006-12-28 | Shiseido Co Ltd | Cleaning composition for skin and hair |
| JP2015113298A (en) * | 2013-12-10 | 2015-06-22 | 花王株式会社 | Cosmetic composition |
| JP2015113297A (en) * | 2013-12-10 | 2015-06-22 | 花王株式会社 | Cosmetic composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2233150C2 (en) | Liquid dispersion polymeric compositions, their preparing and using | |
| KR100298921B1 (en) | Stable o/w/o emulsion and its use as cosmetic and/or dermatological composition | |
| JP2000510840A (en) | Cosmetic composition for skin rejuvenation without skin irritation | |
| KR100884223B1 (en) | Liquid Dispersed Polymer Compositions, Methods for Making the Same, and Uses thereof | |
| WO2003026583A2 (en) | Pullulan based film forming cosmetic compositions | |
| JP4015781B2 (en) | Emulsified composition | |
| JP5743406B2 (en) | Cosmetic or dermatological composition containing a retinoid, an adenosine-based non-phosphated compound and a semi-crystalline polymer | |
| JPH07330538A (en) | Rich cosmetic composition | |
| US20190209453A1 (en) | Use in cosmetics of polymers obtained by low-concentration, inverse emulsion polymerisation with a low level of neutralised monomers | |
| JPH06503566A (en) | Gel-type composition with improved oil control properties | |
| JP2000273031A (en) | Protection cosmetic | |
| US20030215413A1 (en) | Compositions containing stabilized retinoid | |
| EP1605910A1 (en) | Silky feel cosmetic emulsion chassis | |
| JPS59110612A (en) | Hair treatment | |
| JP6739923B2 (en) | Skin cosmetics | |
| JP3291195B2 (en) | Gel cosmetics | |
| JP4049414B2 (en) | Emulsified composition | |
| JP4221273B2 (en) | Emulsified cosmetic | |
| JP2000273019A (en) | Protective cosmetic | |
| JP2001002552A (en) | Skin protective cosmetic | |
| JP2001002554A (en) | Skin protective composition | |
| JP2000281524A (en) | Protection cosmetic | |
| JP2002212051A (en) | Skin care preparation | |
| KR100388692B1 (en) | Stable oil-in-water emulsion, method for preparing same and use in cosmetics and dermatology | |
| JP2002226352A (en) | Skin care preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Effective date: 20060301 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060301 |
|
| RD03 | Notification of appointment of power of attorney |
Effective date: 20060301 Free format text: JAPANESE INTERMEDIATE CODE: A7423 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070523 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20070529 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070723 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070821 |